Skip to content
Screener

Doximity DOCS Investing Cash Flow

Investing Cash Flow at other companies

Microsoft logo
MicrosoftMSFT
-$54.83B-79.4%
Ziff Davis logo
Ziff DavisZD
$1.09B+16,212%
AMN Healthcare logo
AMN HealthcareAMN
-$12.21M+40.7%
Veeva Systems logo
Veeva SystemsVEEV
-$388.71M-646%
OptimizeRx logo
OptimizeRxOPRX
-$21K+75.0%
Teladoc Health logo
Teladoc HealthTDOC
-$41.59M+30.3%

Other financials

Income statement

See full
Revenue$156.6M+7.3%
Gross profit$132.9M+2.2%
Operating income$33.6M-38.3%
Net income$24.3M-54.4%
EPS (diluted)$0.13-51.9%

Balance sheet

See full
Cash & equivalents$273.6M+99.3%
Total debt$9.7M-18.3%
Total equity$916.1M-10.7%
Total assets$1.1B-10.0%

Cash flow

See full
Operating cash flow$42.0M-32.4%
CapEx$62.0K
Free cash flow$41.9M-32.5%

Valuation

See full
Market cap$3.77B-65.4%
Enterprise value$3.5B-67.5%
P/E22.6×-23.8×
P/S5.8×-12.7×

Profitability

See full
Gross margin88.1%-2.1pp
Operating margin29.6%-10.5pp
Net margin25.5%-14.4pp
FCF margin49.9%+15.8pp

Returns & leverage

See full
Return on equity17.2%-7.0pp
Debt / equity0.0×
Current ratio6.1×-0.4×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Doximity’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001516513-26-000040
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Purchases of marketable securities(14,746)(139,934)
Maturities of marketable securities126,071144,579
Sales of marketable securities4,049
Net cash provided by investing activities112,9902,679
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants3,0802,398
Taxes paid related to net share settlement of equity awards(6,974)(11,927)
Repurchase of common stock(91,633)(122,355)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Doximity's investing cash flow?
Doximity (DOCS) reported investing cash flow of $112.99M in Q2 2026.
How has Doximity's investing cash flow changed year-over-year?
Doximity's investing cash flow increased by 4117.6% year-over-year, from $2.68M to $112.99M.
What is the long-term trend for Doximity's investing cash flow?
Over 2 years (2022 to 2026), Doximity's investing cash flow has grown at a -52.1% compound annual growth rate (CAGR), from -$640.57M to $147.17M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Doximity's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude